Loading...
NPI 1386809556 · Bronx, NY · Nuclear Medicine Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Charito Love is a nuclear medicine physician provider located in Bronx, New York. This profile covers 6 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Charito Love |
| Address | 1400 Pelham Pkwy S |
| City | Bronx |
| State | NY |
| ZIP | 10461 |
| Taxonomy | Nuclear Medicine Physician |
| NPI Enumerated | July 27, 2008 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $211.1K |
| Medicaid | $125.7K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
6 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 700 | $220 | $152.2K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 150 | $200 | $29.6K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 70 | $420 | $27.6K |
| 78582 | In this diagnostic procedure, the provider performs both pulmonary ventilation and perfusion imaging in a nuclear scan test that evaluates the circulation of air and blood within the patient’s lungs. | 20 | $50 | $1.1K |
| 78226 | The provider images the liver, bile, bile ducts, and gallbladder to follow the production and flow of bile from the liver to the small intestine to diagnose a bile duct obstruction or leakage;… | 20 | $30 | $740 |
| 82947 | The lab analyst performs a test to measure the amount of glucose in a patient's blood using a method other than a reagent strip. | 20 | $1 | $70 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 6 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 550 | $200 | $108.6K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 310 | $60 | $17.3K |
| 82947 | The lab analyst performs a test to measure the amount of glucose in a patient's blood using a method other than a reagent strip. | 30 | $1 | $30 |
| 82948 | The clinician performs a test to measure the amount of glucose in a patient's blood using a reagent strip test method. | 40 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 21 | 110 | 80 | $570 | $236.2K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 25 | 70 | 90 | $150 | $72.3K |
| 82948 | The clinician performs a test to measure the amount of glucose in a patient's blood using a reagent strip test method. | 211 | 260 | 280 | $1 | $8.7K |
| 82947 | The lab analyst performs a test to measure the amount of glucose in a patient's blood using a method other than a reagent strip. | 293 | 340 | 430 | $1 | $4.1K |
Other providers in the same ZIP code as Charito Love, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| New York City Health And Hospitals Corporation | NY | General Acute Care Hospital | $0 | $217.6M |
| Cupid Homecare Agency | NY | In Home Supportive Care Agency | $0 | $114.1M |
| Citywide Mobile Response Corp | NY | Ambulance | $1.7M | $30.5M |
| Ability Builders For Children, LLC | NY | Early Intervention Provider Agency | $0 | $22.5M |
| New York Gi Center LLC | NY | Endoscopy Clinic/Center | $518.6K | $5.4M |
| Rajesh Bhatnagar | NY | Neurology Physician | $479.2K | $982.2K |
| Gary Tubman | NY | Diagnostic Radiology Physician | $617.9K | $447.2K |
| Eric Wolf | NY | Ophthalmology Physician | $819.6K | $0 |
| Nabil Elhadidy | NY | Internal Medicine Physician | $222.3K | $470K |
| Luciano Tuluca | NY | Pain Medicine (Physical Medicine & Rehabilitation) Physician | $280.8K | $383.8K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.